인쇄하기
취소
|
18 new products, such as a chronic hepatitis C therapy Sovaldi Tab(sofosbuvir), will be registered for the insurance benefit on the 1st of the next month.
There are 9 products each, products with price negotiated between the National Health Insurance Service and pharmaceutical companies and products registered with price lower than the weighted average price.
First, Sovaldi Tab, a Gilead’s ch...